Inventor · disambiguated record
Tuna Mutis
Also filed as: MUTIS TUNA
8 granted patents·10 pending applications·73 citations·filing 2015–2024
87Inventor score
Top patents by PatentIndex Score
18 records- 0195US11396553B2Bispecific anti-CD37 antibodies, monoclonal anti-CD37 antibodies and methods of use thereofGENMAB HOLDING B V·Filed 2021·Granted Jul 26, 2022·8 cites·23 claims
- 0294US11512137B2Bispecific anti-CD37 antibodies, monoclonal anti-CD37 antibodies and methods of use thereofGENMAB HOLDING B V·Filed 2020·Granted Nov 29, 2022·10 cites·10 claims
- 0394US11034772B2Bispecific anti-CD37 antibodies, monoclonal anti-CD37 antibodies and methods of use thereofGENMAB HOLDING B V·Filed 2020·Granted Jun 15, 2021·7 cites·20 claims
- 0494US10668149B2Combination therapies for heme malignancies with anti-CD38 antibodies and survivin inhibitorsJANSSEN BIOTECH INC·Filed 2016·Granted Jun 2, 2020·16 cites·6 claims
- 0592US11021543B2Immune modulation and treatment of solid tumors with antibodies that specifically bind CD38JANSSEN BIOTECH INC·Filed 2018·Granted Jun 1, 2021·13 cites·19 claims
- 0688US10604580B2Combination therapies with anti-CD38 antibodiesJANSSEN BIOTECH INC·Filed 2016·Granted Mar 31, 2020·18 cites·18 claims
- 0780US2025066501A1Immune Modulation and Treatment of Solid Tumors with Antibodies that Specifically Bind CD38JANSSEN BIOTECH INC·Filed 2024·Application pending·0 cites
- 0880US2024117064A1Bispecific anti-cd37 antibodies, monoclonal anti-cd37 antibodies and methods of use thereofGENMAB HOLDING B V·Filed 2022·Application pending·0 cites
- 0977US12448459B2Bispecific anti-CD37 antibodies, monoclonal anti-CD37 antibodies and methods of use thereofGENMAB HOLDING B V·Filed 2021·Granted Oct 21, 2025·0 cites·23 claims
- 1072US12275797B2Anti-CD37 antibodies and anti-CD20 antibodies, compositions and methods of use thereofGENMAB HOLDING B V·Filed 2019·Granted Apr 15, 2025·1 cites·18 claims
- 1169US2021403592A1Immune Modulation and Treatment of Solid Tumors with Antibodies that Specifically Bind CD38JANSSEN BIOTECH INC·Filed 2021·Application pending·0 cites
- 1264US2020270359A1Bispecific anti-cd37 antibodies, monoclonal anti-cd37 antibodies and methods of use thereofGENMAB HOLDING BV·Filed 2018·Application pending·0 cites
- 1359US2023399414A1Bispecific anti-cd37 antibodies, monoclonal anti-cd37 antibodies and methods of use thereofGENMAB HOLDING B V·Filed 2022·Application pending·0 cites
- 1455US2017044265A1Immune Modulation and Treatment of Solid Tumors with Antibodies that Specifically Bind CD38JANSSEN BIOTECH INC·Filed 2016·Application pending·0 cites
- 1553US2023293680A1A composition of anti-dr5 antibodies and an immunomodulatory imide drug for use in treating multiple myelomaGENMAB BV·Filed 2021·Application pending·0 cites
- 1646US2024252635A1Pharmaceutical compositions comprising bispecific anti-cd37 antibodiesGENMAB HOLDING B V·Filed 2019·Application pending·0 cites
- 1739US2016376373A1Immune Modulation and Treatment of Solid Tumors with Antibodies that Specifically Bind CD38JANSSEN BIOTECH INC·Filed 2016·Application pending·0 cites
- 1837US2016067205A1Combination Therapies with Anti-CD38 AntibodiesJANSSEN BIOTECH INC·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Tuna Mutis files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →